These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
928 related articles for article (PubMed ID: 29891648)
61. Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes. Kar D; Bandyopadhyay A Cell Physiol Biochem; 2018; 49(1):245-259. PubMed ID: 30138942 [TBL] [Abstract][Full Text] [Related]
62. Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in pressure-overloaded rat heart. Shyu KG; Liou JY; Wang BW; Fang WJ; Chang H J Biomed Sci; 2005; 12(2):409-20. PubMed ID: 15942707 [TBL] [Abstract][Full Text] [Related]
63. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart. Kinoshita H; Kuwahara K; Nishida M; Jian Z; Rong X; Kiyonaka S; Kuwabara Y; Kurose H; Inoue R; Mori Y; Li Y; Nakagawa Y; Usami S; Fujiwara M; Yamada Y; Minami T; Ueshima K; Nakao K Circ Res; 2010 Jun; 106(12):1849-60. PubMed ID: 20448219 [TBL] [Abstract][Full Text] [Related]
64. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure. Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042 [TBL] [Abstract][Full Text] [Related]
65. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis. Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543 [TBL] [Abstract][Full Text] [Related]
66. Unfavourable consequences of chronic cardiac HIF-1α stabilization. Hölscher M; Schäfer K; Krull S; Farhat K; Hesse A; Silter M; Lin Y; Pichler BJ; Thistlethwaite P; El-Armouche A; Maier LS; Katschinski DM; Zieseniss A Cardiovasc Res; 2012 Apr; 94(1):77-86. PubMed ID: 22258630 [TBL] [Abstract][Full Text] [Related]
67. Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+/calmodulin-dependent protein kinase II signaling. Bisserier M; Berthouze-Duquesnes M; Breckler M; Tortosa F; Fazal L; de Régibus A; Laurent AC; Varin A; Lucas A; Branchereau M; Marck P; Schickel JN; Deloménie C; Cazorla O; Soulas-Sprauel P; Crozatier B; Morel E; Heymes C; Lezoualc'h F Circulation; 2015 Jan; 131(4):390-400; discussion 400. PubMed ID: 25369805 [TBL] [Abstract][Full Text] [Related]
68. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy. Liu L; An X; Li Z; Song Y; Li L; Zuo S; Liu N; Yang G; Wang H; Cheng X; Zhang Y; Yang X; Wang J Cardiovasc Res; 2016 Jul; 111(1):56-65. PubMed ID: 27084844 [TBL] [Abstract][Full Text] [Related]
69. Over-expression of hypoxia-inducible factor-1 alpha in vitro protects the cardiac fibroblasts from hypoxia-induced apoptosis. Yang B; He K; Zheng F; Wan L; Yu X; Wang X; Zhao D; Bai Y; Chu W; Sun Y; Lu Y J Cardiovasc Med (Hagerstown); 2014 Jul; 15(7):579-86. PubMed ID: 24583668 [TBL] [Abstract][Full Text] [Related]
70. A simplified protocol for culture of murine neonatal cardiomyocytes on nanoscale keratin coated surfaces. Jain A; Ravi V; Muhamed J; Chatterjee K; Sundaresan NR Int J Cardiol; 2017 Apr; 232():160-170. PubMed ID: 28096043 [TBL] [Abstract][Full Text] [Related]
71. Type III Transforming Growth Factor-β Receptor Drives Cardiac Hypertrophy Through β-Arrestin2-Dependent Activation of Calmodulin-Dependent Protein Kinase II. Lou J; Zhao D; Zhang LL; Song SY; Li YC; Sun F; Ding XQ; Yu CJ; Li YY; Liu MT; Dong CJ; Ji Y; Li H; Chu W; Zhang ZR Hypertension; 2016 Sep; 68(3):654-66. PubMed ID: 27432858 [TBL] [Abstract][Full Text] [Related]
72. Long Noncoding RNA Yu J; Yang Y; Xu Z; Lan C; Chen C; Li C; Chen Z; Yu C; Xia X; Liao Q; Jose PA; Zeng C; Wu G Circ Heart Fail; 2020 Jan; 13(1):e006525. PubMed ID: 31957467 [TBL] [Abstract][Full Text] [Related]
73. Activation of hypoxia-inducible factor-2 in adipocytes results in pathological cardiac hypertrophy. Lin Q; Huang Y; Booth CJ; Haase VH; Johnson RS; Celeste Simon M; Giordano FJ; Yun Z J Am Heart Assoc; 2013 Dec; 2(6):e000548. PubMed ID: 24326162 [TBL] [Abstract][Full Text] [Related]
74. Involvement of calcium-sensing receptor in cardiac hypertrophy-induced by angiotensinII through calcineurin pathway in cultured neonatal rat cardiomyocytes. Wang LN; Wang C; Lin Y; Xi YH; Zhang WH; Zhao YJ; Li HZ; Tian Y; Lv YJ; Yang BF; Xu CQ Biochem Biophys Res Commun; 2008 May; 369(2):584-9. PubMed ID: 18295598 [TBL] [Abstract][Full Text] [Related]
75. MicroRNA-297 promotes cardiomyocyte hypertrophy via targeting sigma-1 receptor. Bao Q; Zhao M; Chen L; Wang Y; Wu S; Wu W; Liu X Life Sci; 2017 Apr; 175():1-10. PubMed ID: 28286226 [TBL] [Abstract][Full Text] [Related]
76. Carboxypeptidase A4 promotes cardiomyocyte hypertrophy through activating PI3K-AKT-mTOR signaling. Gao W; Guo N; Zhao S; Chen Z; Zhang W; Yan F; Liao H; Chi K Biosci Rep; 2020 May; 40(5):. PubMed ID: 32347291 [TBL] [Abstract][Full Text] [Related]
77. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades. Dai H; Jia G; Liu X; Liu Z; Wang H Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447 [TBL] [Abstract][Full Text] [Related]
78. KLK11 promotes the activation of mTOR and protein synthesis to facilitate cardiac hypertrophy. Wang Y; Liao H; Wang Y; Zhou J; Wang F; Xie Y; Zhao K; Gao W BMC Cardiovasc Disord; 2021 May; 21(1):266. PubMed ID: 34059001 [TBL] [Abstract][Full Text] [Related]
79. Heat-shock-protein 90 protects from downregulation of HIF-1α in calcineurin-induced myocardial hypertrophy. Eschricht S; Jarr KU; Kuhn C; Lehmann L; Kreusser M; Katus HA; Frey N; Chorianopoulos E J Mol Cell Cardiol; 2015 Aug; 85():117-26. PubMed ID: 26031702 [TBL] [Abstract][Full Text] [Related]
80. Adrenomedullin is a regulated modulator of neonatal cardiomyocyte hypertrophy in vitro. Autelitano DJ; Ridings R; Tang F Cardiovasc Res; 2001 Aug; 51(2):255-64. PubMed ID: 11470465 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]